CSB601 2018 Group Assignment: Case Study Analysis of Mary's Medication
Verified
Added on 2023/06/08
|3
|571
|344
AI Summary
This group assignment for CSB601 2018 involves a case study analysis of Mary's medication. The group discusses the effects of the prescribed drugs on Mary's health, their safety and effectiveness. The analysis reveals that some of the drugs prescribed are not safe and effective for Mary's condition.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.
CSB601 2018 Group assignment Group Name, Case Patient Chosen (Mary or Dennis) Workshop Day, Workshop Time, Group# Group Leader Name, Student Number Team Member 2 Name, Student Number Team Member 3 Name, Student Number Team Member 4 Name, Student Number Team Member 5 Name, Student Number Team Member 6 Name, Student Number
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
ASE-C-POP Appropriate On thoroughly analysing the case study, it can be said that the drugs that are prescribed to Mary have the following effects: Metformin CR 2g daily : In order to control Type II Diabetes Perindopril 5mg daily (started 2 years ago) : In order to control the elevated Blood Pressure Metoprolol CR 47.5mg daily (started several months ago): To control chest pain Furosemide 40mg daily (started several months ago) : To treat fluid build-up in the chest Diclofenac 50 mg 1 tablet three times daily (started last week): In order to provide pain relief and reduce inflammation On studying the current medication that is being administered to the patient, it can be said that the patient is regularly taking Perindropil but the elevated blood pressure is still not under control. The administration of Metformin for treating Diabetes type II has long been obsolete specifically to patients who have a cardiac disorder. It should also be noted that despite taking Metoprolol for a several months, the chest pain has yet not been under control and the patient is complaining of shortness of breath. Safe The administration of Metformin to treat Diabetes type II in individuals with heart disorder is not safe as it impedes with the proper cardiac functioning [1] Administration of Metoprolol is absolutely not safe for patients who are suffering from Diabetes type II or possess a heart failure history as per the QUM as it can seriously affect the glucose level in the blood [2],[3]. Hence, it can be said that the drugs that have been prescribed are impeding with the normal physiological functions of the body and are eliciting severe side-effects. Hence, the issue should be addressed immediately. ective It can be said that the present medication that is being used for the patient is not effective as it is eliciting side effects and hampering the normal body functioning.
References American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes care. 2014 Jan 1;37(Supplement 1):S14-80. Weber, M.A., Schiffrin, E.L., White, W.B., Mann, S., Lindholm, L.H., Kenerson, J.G., Flack, J.M., Carter, B.L., Materson, B.J., Ram, C.V.S. and Cohen, D.L., 2014. Clinical practice guidelines for the management of hypertension in the community: a statementby the American Society of Hypertension and the International Society of Hypertension. The journal of clinical hypertension, 16(1), pp.14-26. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet. 1998 Sep 12;352(9131):854-65.